Identification of stage I/II melanoma patients at high risk for recurrence using a model combining clinicopathologic factors with gene expression profiling (CP-GEP)-Reference-Cited by-同舟云学术

Identification of stage I/II melanoma patients at high risk for recurrence using a model combining clinicopathologic factors with gene expression profiling (CP-GEP)

Published:2023-03 Issue: Volume:182 Page:155-162
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Amaral Teresa^ORCID,Sinnberg Tobias,Chatziioannou Eftychia,Niessner Heike,Leiter Ulrike^ORCID,Keim Ulrike,Forschner Andrea^ORCID,Dwarkasing Jvalini,Tjien-Fooh Félicia,Wever Renske^ORCID,Flatz Lukas,Eggermont Alexander,Forchhammer Stephan^ORCID

Funder

SkylineDx

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference23 articles.

1. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial;Eggermont;Lancet Oncol,2015

2. Adjuvant Nivolumab versus ipilimumab in resected stage III or IV melanoma [Internet];Weber;N Engl J Med,2017

3. Adjuvant pembrolizumab versus placebo in resected stage III melanoma;Eggermont;N Engl J Med,2018

4. The new era of adjuvant therapies for melanoma [Internet];Eggermont;Nat Rev Clin Oncol,2018

5. Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial;Luke;Lancet,2022

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical, dermatoscopic, histological and molecular predictive factors of distant melanoma metastasis: A systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2024-10

2. Circulating tumor DNA-based assessment of molecular residual disease in non-metastatic melanoma;Cancer Treatment Reviews;2024-09

3. Finally! An Improved Prognostic Calculator for Cutaneous Melanoma;Annals of Surgical Oncology;2024-07-06

4. Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy;European Journal of Cancer;2024-05

5. The Use of Gene Expression Profiling and Biomarkers in Melanoma Diagnosis and Predicting Recurrence: Implications for Surveillance and Treatment;Cancers;2024-01-30